课题基金 / 基金详情

Corticosteroid irrigation of parotid gland for treatment of xerostomia in patients with Sjogren's syndrome

Corticosteroid irrigation of parotid gland for treatment of xerostomia in patients with Sjogren's syndrome
腮腺皮质类固醇冲洗治疗干燥综合征患者口干症
批准号:
09671927
负责人:
IZUMI Masahiro
金额:
$2.05万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1997
资助国家:
日本
项目状态:
已结题
起止时间:
1997 至 1998

项目摘要

项目成果

IZUMI Masahiro的其他基金

相似基金

相关文献

中文摘要
翻译
为探讨激素腮腺冲洗对缓解干燥综合征患者唾液流动不足的疗效,对39例原发性干燥综合征患者(29例)和10例继发性干燥综合征患者(10例)分别用生理盐水和激素溶液冲洗腮腺。用撒克逊试验评估唾液功能。激素冲洗使干燥综合征患者的唾液流率显著增加(p<0.0001),首次皮质激素冲洗后临床症状改善4.0“*”2.6周。唾液功能改善的程度与病情严重程度成反比,早期患者唾液流率净增加1.20×0.57g,晚期患者净增加0.20×0.47g。反复类固醇冲洗没有引起唾液腺的类固醇不耐受;在这些患者中,在第二次到第四次皮质类固醇激发后,观察到类似水平的唾液流率净增加。持续时间为8.6个月,提示糖皮质激素冲洗疗法在缓解干燥综合征患者口干症方面有临床应用价值。
英文摘要
The purpose of this study was to determine the efficacy of corticosteroid irrigation of the parotid gland in relieving salivary flow deficiency in patients with Sjogren's syndrome.The parotid glands of thirty-nine patients with primary (twenty nine) or secondary (ten) Sjogren's syndrome were irrigated either with saline solution followed by corticosteroid solution. Salivary function was assessed by Saxon test.Corticosteroid irrigation significantly increased the salivary flow rate in patients with Sjogren's syndrome (p< 0.0001), with clinical improvement detectable 4.0 "*" 2.6 weeks after initial corticosteroid irrigation. The extent of improvement in salivary function was reciprocal to the clinical severity of the disease, with patients at the early stages obtaining 1.20*0.57 g net increase in salivary flow rate, and patients at the most advanced stages obtaining 0.20 "*" 0.47 g net increase. Repeated steroid irrigations did not evoke steroid refractoriness of the salivary gland ; similar levels of net increase in salivary flow rate were observed after the second to fourth challenge of the corticosteroid in these patients. The sustained period was 8.6 months.These findings suggest the clinical usefulness of corticosteroid irrigation therapy in relieving xerostomia in patients with Sjogren's syndrome.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
M.Izumi, K.Eguchi, H.Nakamura, Y.Takagi, Y.Kawabe, T.Nakamura: "Corticosteroid irrigation of parotid gland for treatment of xerostomia in patients with Sjogren's syndrome." Ann Rheum Dis. 57. 464-469 (1998)
M.Izumi、K.Eguchi、H.Nakamura、Y.Takagi、Y.Kawabe、T.Nakamura:“腮腺皮质类固醇冲洗用于治疗干燥综合征患者的口干症。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Izumi M.,他6名: "MR features of the lacrimal gland in Sjogren's syndrome" AJR. 170. 1661-1666 (1998)
Izumi M. 和其他 6 人:“干燥综合征泪腺的 MR 特征”AJR 170. 1661-1666 (1998)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
M.Izumi, K.Eguchi, H.Nakamura, S.Nagataki, T.Nakamura: "Premature fat deposition in salivary glands affected by Sjogren's syndrome : Evidence by MR and CT." AJNR. 18. 951-958 (1997)
M.Izumi、K.Eguchi、H.Nakamura、S.Nagataki、T.Nakamura:“受干燥综合征影响的唾液腺过早脂肪沉积:MR 和 CT 证据。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Izumi M.,他4名: "Premature fat deposition in salivary glands affected by Sjogren's syndrome;Evidence by MR and CT" AJNR. 18. 951-958 (1997)
Izumi M. 和其他 4 人:“受干燥综合征影响的唾液腺中的过早脂肪沉积;MR 和 CT 的证据”AJNR。18. 951-958 (1997)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
9
    Mental stress on saliva chromogranin A in dry mouth
    • 批准号:
      15592010
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.37万
    • 财政年份:
      2003
    • 负责人:
      IZUMI Masahiro
    • 依托单位:
    Sjogren's Syndrome in patients with HTLV-I-associated myelopathy(HAM) :
    • 批准号:
      11671872
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.18万
    • 财政年份:
      1999
    • 负责人:
      IZUMI Masahiro
    • 依托单位:
    国内基金
    海外基金
    多模态MRI脊髓微结构成像技术在脊髓型颈椎病诊治中的作用研究
    • 批准号:
      JCZRLH202601272
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    基于多模态MRI评估早期抑郁症患者脑类淋巴系统异常改变的研究
    基于人工智能和多模态MRI的股骨头坏死塌陷风险预测研究
    • 批准号:
      JCZRLH202600607
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    靶向Na⁺-糖酵解轴:²³Na-MRI无创评估宫颈癌化疗耐药与疗效预测研究
    • 批准号:
      JCZRLH202600284
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位: